{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:34:21Z","timestamp":1777516461287,"version":"3.51.4"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["406035\/2021\\u20130"],"award-info":[{"award-number":["406035\/2021\\u20130"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["313295\/2023\\u20139"],"award-info":[{"award-number":["313295\/2023\\u20139"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["311580\/2021\\u20131"],"award-info":[{"award-number":["311580\/2021\\u20131"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010972","name":"National Institute of Science and Technology for Nanobiopharmaceuticals","doi-asserted-by":"publisher","award":["465671\/2014\\u20134"],"award-info":[{"award-number":["465671\/2014\\u20134"]}],"id":[{"id":"10.13039\/501100010972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005284","name":"Secretaria de Estado do Desenvolvimento Econ\u00f4mico e Social","doi-asserted-by":"publisher","award":["421630\/2022\\u20131"],"award-info":[{"award-number":["421630\/2022\\u20131"]}],"id":[{"id":"10.13039\/501100005284","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["17\/2551-0000903-7"],"award-info":[{"award-number":["17\/2551-0000903-7"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["23\/2551-0000919-6"],"award-info":[{"award-number":["23\/2551-0000919-6"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["14\/2022"],"award-info":[{"award-number":["14\/2022"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrc.2025.152523","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:48:19Z","timestamp":1755877699000},"page":"152523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In vitro anticancer potential of selenocyanate-containing dihydropyrimidinone compounds against glioma"],"prefix":"10.1016","volume":"781","author":[{"given":"Pauline Rafaela","family":"Pizzato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliete Nathali","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luma Smidt","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Alf","family":"da Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-6291","authenticated-orcid":false,"given":"Itamar Lu\u00eds","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2935-9944","authenticated-orcid":false,"given":"Gustavo Machado","family":"das Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera Lucia","family":"Eifler-Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0858-830X","authenticated-orcid":false,"given":"R\u00f4mulo F.S.","family":"Canto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabr\u00edcio","family":"Figueir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.bbrc.2025.152523_bib1","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.2174\/0929867324666170516123206","article-title":"Glioblastoma multiforme, diagnosis and treatment; recent literature review","volume":"24","author":"Batash","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152523_bib2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjmed.2017.12.039","article-title":"Brain tumors","volume":"131","author":"McFaline-Figueroa","year":"2018","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152523_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11910-021-01152-9","article-title":"Epidemiology of brain and other CNS tumors","volume":"21","author":"Ostrom","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bbrc.2025.152523_bib4","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3389\/fimmu.2020.01402","article-title":"Molecular heterogeneity and immunosuppressive microenvironment in glioblastoma","volume":"11","author":"DeCordova","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152523_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2015.05.005","article-title":"Glioblastoma multiforme: pathogenesis and treatment","volume":"152","author":"Alifieris","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.bbrc.2025.152523_bib6","first-page":"2613","article-title":"Survival analysis of glioblastoma multiforme","volume":"19","author":"Witthayanuwat","year":"2018","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"10","key":"10.1016\/j.bbrc.2025.152523_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2176\/nmc.ra.2018-0141","article-title":"Potential strategies overcoming the temozolomide resistance for glioblastoma","volume":"58","author":"Jiapaer","year":"2018","journal-title":"Neurol. Med.-Chir."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152523_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152523_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/ed009p474","article-title":"The discovery of the elements. VI. Tellurium and selenium","volume":"9","author":"Weeks","year":"1932","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.bbrc.2025.152523_bib10","unstructured":"Stadtman TC. Some functions of the essential trace element, selenium. In: Springer NY, NY, editor. Trace Elements in Man and Animals 102002."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152523_bib11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1515\/BC.2007.138","article-title":"Selenium in chemistry and biochemistry in comparison to sulfur","volume":"388","author":"Wessjohann","year":"2007","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152523_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.bi.65.070196.000503","article-title":"Selenocysteine","volume":"65","author":"Stadtman","year":"1996","journal-title":"Annu. Rev. Biochem."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152523_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24071298","article-title":"Selenium-fascinating microelement, properties and sources in food","volume":"24","author":"Kieliszek","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152523_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10787-020-00690-x","article-title":"Selenium and selenoproteins: it's role in regulation of inflammation","volume":"28","author":"Hariharan","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bbrc.2025.152523_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejca.2021.07.013","article-title":"Selenium stimulates the antitumour immunity: insights to future research","volume":"155","author":"Razaghi","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.bbrc.2025.152523_bib16","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1021\/ar100059g","article-title":"Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants","volume":"43","author":"Bhabak","year":"2010","journal-title":"Acc. Chem. Res."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152523_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102209","article-title":"A summary of new findings on the biological effects of selenium in selected animal Species-A critical review","volume":"18","author":"Hosnedlova","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"30","key":"10.1016\/j.bbrc.2025.152523_bib18","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.2174\/092986711797379249","article-title":"Selenium and clinical trials: new therapeutic evidence for multiple diseases","volume":"18","author":"Sanmartin","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152523_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113384","article-title":"New organoselenides (NSAIDs-Se derivatives) as potential anticancer agents: synthesis, biological evaluation and in silico calculations","volume":"218","author":"He","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152523_bib20","series-title":"Encyclopedia of Inorganic Chemistry","article-title":"Selenium: organoselenium chemistry","author":"Back","year":"2006"},{"issue":"11","key":"10.1016\/j.bbrc.2025.152523_bib21","doi-asserted-by":"crossref","DOI":"10.2174\/138527211795656642","article-title":"Organic selenocyanates: synthesis, characterization and uses in chemistry and biology","volume":"15","author":"Guillemin","year":"2011","journal-title":"Curr. Org. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152523_bib22","first-page":"470","article-title":"Vistas in the domain of organoselenocyanates","volume":"2014","author":"Shaaban","year":"2014"},{"key":"10.1016\/j.bbrc.2025.152523_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102337","article-title":"Small-molecule organoselenocyanates: recent developments toward synthesis, anticancer, and antioxidant activities","volume":"75","author":"Badirujjaman","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152523_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1039\/C9CC07683B","article-title":"Rational design and action mechanisms of chemically innovative organoselenium in cancer therapy","volume":"56","author":"Chen","year":"2019","journal-title":"Chem. Commun."},{"issue":"45","key":"10.1016\/j.bbrc.2025.152523_bib25","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1039\/C8OB01891J","article-title":"Potent anti-proliferative activities of organochalcogenocyanates towards breast cancer","volume":"16","author":"Banerjee","year":"2018","journal-title":"Org. Biomol. Chem."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152523_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10040590","article-title":"New amides and phosphoramidates containing selenium: studies on their cytotoxicity and antioxidant activities in breast cancer","volume":"10","author":"Etxebeste-Mitxeltorena","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2025.152523_bib27","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.biopha.2016.11.006","article-title":"Sensitization of cancer cells to cyclophosphamide therapy by an organoselenium compound through ROS-mediated apoptosis","volume":"84","author":"Chakraborty","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2025.152523_bib28","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.ejmech.2017.10.073","article-title":"Biological activity of dihydropyrimidinone (DHPM) derivatives: a systematic review","volume":"143","author":"Matos","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152523_bib29","series-title":"Dihydropyrimidinones Inhibit Proliferation and Tumor Growth. Dihydropyrimidinones as Potent Anticancer Agents","first-page":"243","author":"Lone","year":"2023"},{"issue":"6","key":"10.1016\/j.bbrc.2025.152523_bib30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1039\/C8MD00095F","article-title":"Effect of N-1 arylation of monastrol on kinesin Eg5 inhibition in glioma cell lines","volume":"9","author":"Gon\u00e7alves","year":"2018","journal-title":"MedChemComm"},{"issue":"12","key":"10.1016\/j.bbrc.2025.152523_bib31","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4155\/fmc-2019-0256","article-title":"New pharmacological findings linked to biphenyl DHPMs, kinesin Eg5 ligands: anticancer and antioxidant effects","volume":"12","author":"Gon\u00e7alves","year":"2020","journal-title":"Future Med. Chem."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152523_bib32","first-page":"1","article-title":"Multicomponent reactions in the last 30 years: how are we today?","volume":"35","author":"de Lima","year":"2024","journal-title":"J. Braz. Chem. Soc."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152523_bib33","first-page":"1837","article-title":"A monastrol-derived compound, LaSOM 63, inhibits ecto-5'nucleotidase\/CD73 activity and induces apoptotic cell death of glioma cell lines","volume":"34","author":"Figueir\u00f3","year":"2014","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152523_bib34","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1590\/S0103-50532011000700025","article-title":"Synthesis of dihydropyrimidin-2-one\/thione library and cytotoxic activity against the human U138-MG and Rat C6 glioma cell lines","volume":"22","author":"Canto","year":"2011","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.bbrc.2025.152523_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100718","article-title":"Advances in the discovery of DHPMs as Eg5 inhibitors for the management of breast cancer and glioblastoma: a review","volume":"5","author":"Nikam","year":"2023","journal-title":"Results Chem."},{"issue":"15","key":"10.1016\/j.bbrc.2025.152523_bib36","doi-asserted-by":"crossref","first-page":"10581","DOI":"10.1021\/acs.jmedchem.1c00683","article-title":"Rational multitargeted drug design strategy from the perspective of a medicinal chemist","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152523_bib37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acs.jmedchem.8b00760","article-title":"Polypharmacology by design: a medicinal chemist's perspective on multitargeting compounds","volume":"62","author":"Proschak","year":"2019","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bbrc.2025.152523_bib38","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","article-title":"Molecular hybridization: a useful tool in the design of new drug prototypes","volume":"14","author":"Viegas-Junior","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"19","key":"10.1016\/j.bbrc.2025.152523_bib39","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","article-title":"Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases","volume":"19","author":"Ivasiv","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152523_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152523_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2174\/1385272823666191021124443","article-title":"Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases","volume":"18","author":"Gontijo","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"21","key":"10.1016\/j.bbrc.2025.152523_bib42","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1039\/C4OB00598H","article-title":"Design, synthesis and evaluation of seleno-dihydropyrimidinones as potential multi-targeted therapeutics for Alzheimer's disease","volume":"12","author":"Canto","year":"2014","journal-title":"Org. Biomol. Chem."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152523_bib43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/092986708783503212","article-title":"From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage","volume":"15","author":"Petrelli","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152523_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejmech.2016.04.024","article-title":"Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach","volume":"117","author":"Yu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152523_bib45","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s40495-018-0160-3","article-title":"The anticancer and chemopreventive activity of selenocyanate-containing compounds","volume":"4","author":"Ali","year":"2018","journal-title":"Current Pharmacol. Rep."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152523_bib46","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3390\/futurepharmacol2040036","article-title":"Selenium-Based drug development for antioxidant and anticancer activity","volume":"2","author":"Debnath","year":"2022","journal-title":"Future Pharmacol."},{"issue":"40","key":"10.1016\/j.bbrc.2025.152523_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202401741","article-title":"Evaluation of electrochemical behavior and antioxidant activity of seleno\u2010dihydropyrimidinones and chloro\u2010dihydropyrimidinones","volume":"9","author":"Eltz da Rosa","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bbrc.2025.152523_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuro.2021.10.012","article-title":"Dihydropyrimidinone-derived selenoesters efficacy and safety in an in vivo model of A\u03b2 aggregation","volume":"88","author":"Pereira","year":"2022","journal-title":"Neurotoxicology"},{"issue":"22","key":"10.1016\/j.bbrc.2025.152523_bib49","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1016\/j.bmc.2016.09.031","article-title":"Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease","volume":"24","author":"Barbosa","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152523_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bbrc.2025.152523_bib51","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"W1","key":"10.1016\/j.bbrc.2025.152523_bib52","doi-asserted-by":"crossref","first-page":"W469","DOI":"10.1093\/nar\/gkae254","article-title":"Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction","volume":"52","author":"Myung","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.bbrc.2025.152523_bib53","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.152523_bib54","series-title":"VEGA-QSAR: AI Inside a Platform for Predictive Toxicology. Popularize Artificial Intelligence 2013: Proceedings of the Workshop on Popularize Artificial Intelligence (PAI 2013) Turin","author":"Benfenati","year":"2013"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152523_bib55","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1166\/jbn.2013.1547","article-title":"Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth","volume":"9","author":"Figueir\u00f3","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152523_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032914","article-title":"Optimization of the hemolysis assay for the assessment of cytotoxicity","volume":"24","author":"S\u00e6b\u00f8","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152523_bib57","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejps.2010.04.014","article-title":"Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction","volume":"40","author":"Kiss","year":"2010","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152523_bib58","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jlb.55.2.253","article-title":"Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells","volume":"55","author":"Carter","year":"1994","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152523_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1039\/C3MT00185G","article-title":"Selenium biochemistry and its role for human health","volume":"6","author":"Roman","year":"2014","journal-title":"Metallomics"},{"issue":"6","key":"10.1016\/j.bbrc.2025.152523_bib60","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1021\/acs.jmedchem.8b00128","article-title":"Synthesis and biological evaluation of selenium-containing 4-Anilinoquinazoline derivatives as novel antimitotic agents","volume":"61","author":"An","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152523_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/bs.acr.2017.07.007","article-title":"Selenocompounds in cancer therapy: an overview","volume":"136","author":"Bartolini","year":"2017","journal-title":"Adv. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152523_bib62","first-page":"151","article-title":"Inhibition of DMBA-croton oil two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate through modulation of cutaneous oxidative stress and inhibition of nitric oxide production","volume":"5","author":"Das","year":"2004","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.bbrc.2025.152523_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117086","article-title":"Synthesis of estrone selenocyanate compounds, anti-tumor activity evaluation and structure-activity relationship analysis","volume":"76","author":"Huang","year":"2022","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152523_bib64","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.3390\/nu7053536","article-title":"Redox-active selenium compounds--from toxicity and cell death to cancer treatment","volume":"7","author":"Misra","year":"2015","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.bbrc.2025.152523_bib65","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.3390\/ijms13089649","article-title":"Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy","volume":"13","author":"Sanmart\u00edn","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152523_bib66","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejmech.2015.03.062","article-title":"Novel hybrid DHPM-fatty acids: synthesis and activity against glioma cell growth in vitro","volume":"95","author":"Treptow","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152523_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.666679","article-title":"Therapeutic potential of selenium in glioblastoma","volume":"15","author":"Yakubov","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbrc.2025.152523_bib68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejmech.2014.01.060","article-title":"Multifunctional compounds: smart molecules for multifactorial diseases","volume":"76","author":"Bansal","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152523_bib69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejmech.2012.11.044","article-title":"Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent","volume":"60","author":"Sashidhara","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152523_bib70","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejmech.2018.06.026","article-title":"Novel pyrimidinic selenourea induces DNA damage, cell cycle arrest, and apoptosis in human breast carcinoma","volume":"155","author":"Barbosa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152523_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072116","article-title":"Mechanisms of resistance and Current treatment options for glioblastoma multiforme (GBM)","volume":"15","author":"Yalamarty","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bbrc.2025.152523_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020367","article-title":"Pharmaceutical and safety profile evaluation of novel selenocompounds with noteworthy anticancer activity","volume":"14","author":"Mar\u0107","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbrc.2025.152523_bib73","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejmech.2019.04.074","article-title":"Organoseleno cytostatic derivatives: Autophagic cell death with AMPK and JNK activation","volume":"175","author":"Garnica","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152523_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201900603","article-title":"Synthesis and potential anticancer activity of some novel selenocyanates and diselenides","volume":"17","author":"Nie","year":"2020","journal-title":"Chem. Biodivers."},{"issue":"24","key":"10.1016\/j.bbrc.2025.152523_bib75","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1021\/jm800993r","article-title":"Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates","volume":"51","author":"Sharma","year":"2008","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152523_bib76","first-page":"3631","article-title":"Effects of organoselenium compounds on induction of mouse forestomach tumors by benzo(a)pyrene","volume":"45","author":"el-Bayoumy","year":"1985","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152523_bib77","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2174\/0929867043365053","article-title":"Organoselenium compounds as potential therapeutic and chemopreventive agents: a review","volume":"11","author":"Soriano-Garcia","year":"2004","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152523_bib78","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4155\/fmc-2019-0227","article-title":"1,2,3-Triazole tethered 2-mercaptobenzimidazole derivatives: design, synthesis and molecular assessment toward C6 glioma cell line","volume":"12","author":"Andrade","year":"2020","journal-title":"Future Med. Chem."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152523_bib79","first-page":"2993","article-title":"Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells","volume":"29","author":"Badisa","year":"2009","journal-title":"Anticancer Res."},{"issue":"20","key":"10.1016\/j.bbrc.2025.152523_bib80","first-page":"7479","article-title":"Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways","volume":"61","author":"Ghose","year":"2001","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152523_bib81","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/inorganics10120246","article-title":"Organoselenocyanates tethered methyl anthranilate hybrids with promising anticancer, antimicrobial, and antioxidant activities","volume":"10","author":"Al-Abdallah","year":"2022","journal-title":"Inorganics"},{"key":"10.1016\/j.bbrc.2025.152523_bib82","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.3390\/molecules27217477","article-title":"Unveiling a new selenocyanate as a multitarget candidate with anticancer, antileishmanial and antibacterial potential","volume":"27","author":"Ramos-Inza","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bbrc.2025.152523_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21081013","article-title":"Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from Bursera fagaroides var. fagaroides on breast cancer cell lines","volume":"21","author":"Pe\u00f1a-Mor\u00e1n","year":"2016","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152523_bib84","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1038\/s41598-023-35045-3","article-title":"4-Methylumbelliferone enhances the effects of chemotherapy on both temozolomide-sensitive and resistant glioblastoma cells","volume":"13","author":"Pibuel","year":"2023","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bbrc.2025.152523_bib85","article-title":"Acetogenins-Rich fractions of","volume":"28","author":"Sousa","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2025.152523_bib86","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbi.2017.11.007","article-title":"Erythrocytes as a biological model for screening of xenobiotics toxicity","volume":"279","author":"Farag","year":"2018","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152523_bib87","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11011-020-00624-0","article-title":"Selenium prevents interferon-gamma induced activation of TRPM2 channel and inhibits inflammation, mitochondrial oxidative stress, and apoptosis in microglia","volume":"36","author":"Akyuva","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152523_bib88","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11011-019-00428-x","article-title":"Mitochondrial oxidative stress-induced brain and hippocampus apoptosis decrease through modulation of caspase activity, Ca","volume":"34","author":"Ataizi","year":"2019","journal-title":"Metab. Brain Dis."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152523_bib89","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s12640-019-0009-5","article-title":"Selenium enhances the apoptotic efficacy of docetaxel through activation of TRPM2 channel in DBTRG glioblastoma cells","volume":"35","author":"Ertilav","year":"2019","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152523_bib90","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/WNR.0000000000001386","article-title":"Selenium nanoparticles reduce glucose metabolism and promote apoptosis of glioma cells through reactive oxygen species-dependent manner","volume":"31","author":"Xu","year":"2020","journal-title":"Neuroreport"},{"issue":"5441","key":"10.1016\/j.bbrc.2025.152523_bib94","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.286.5441.971","article-title":"Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen","volume":"286","author":"Mayer","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bbrc.2025.152523_bib95","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1083\/jcb.150.5.975","article-title":"Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5","volume":"150","author":"Kapoor","year":"2000","journal-title":"J. Cell Biol."},{"issue":"20","key":"10.1016\/j.bbrc.2025.152523_bib96","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1016\/j.bmc.2011.08.044","article-title":"Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathway","volume":"19","author":"Krishnegowda","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152523_bib97","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/1940-6207.CAPR-10-0106","article-title":"Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4","volume":"4","author":"Nguyen","year":"2011","journal-title":"Cancer Prev. Res."},{"issue":"13","key":"10.1016\/j.bbrc.2025.152523_bib98","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1158\/1078-0432.CCR-10-2370","article-title":"The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model","volume":"17","author":"Sharma","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152523_bib99","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1158\/1078-0432.CCR-08-2214","article-title":"Targeting Akt3 signaling in malignant melanoma using isoselenocyanates","volume":"15","author":"Sharma","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.bbrc.2025.152523_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914574","article-title":"Oxidative damage as a fundament of systemic toxicities induced by cisplatin-the crucial limitation or potential therapeutic target?","volume":"24","author":"Katani\u0107 Stankovi\u0107","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152523_bib101","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.abb.2015.06.024","article-title":"Selenoproteins: antioxidant selenoenzymes and beyond","volume":"595","author":"Steinbrenner","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"issue":"49","key":"10.1016\/j.bbrc.2025.152523_bib102","doi-asserted-by":"crossref","first-page":"16699","DOI":"10.1002\/chem.201303339","article-title":"Catalytic reduction of graphene oxide nanosheets by glutathione peroxidase mimetics reveals a new structural motif in graphene oxide","volume":"19","author":"Vernekar","year":"2013","journal-title":"Chemistry."},{"issue":"34","key":"10.1016\/j.bbrc.2025.152523_bib103","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.1039\/C9NJ02227A","article-title":"Free radical induced selenoxide formation in isomeric organoselenium compounds: the effect of chemical structures on antioxidant activity","volume":"43","author":"Singh","year":"2019","journal-title":"New J. Chem."},{"issue":"17","key":"10.1016\/j.bbrc.2025.152523_bib104","doi-asserted-by":"crossref","first-page":"12984","DOI":"10.1021\/acs.inorgchem.1c01410","article-title":"Benzimidazole- and imidazole-fused selenazolium and selenazinium selenocyanates: ionic organoselenium compounds with efficient peroxide scavenging activities","volume":"60","author":"Banerjee","year":"2021","journal-title":"Inorg. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25012380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25012380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:58:46Z","timestamp":1777391926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25012380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":101,"alternative-id":["S0006291X25012380"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152523","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro anticancer potential of selenocyanate-containing dihydropyrimidinone compounds against glioma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152523"}}